ClinicalTrials.Veeva

Menu

Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France (INCOVPED)

U

University Hospital, Lille

Status

Completed

Conditions

COVID
Infection Viral
Coronavirus

Treatments

Diagnostic Test: nasopharyngeal swab

Study type

Observational

Funder types

Other

Identifiers

NCT04336761
2020_21
2020-A00811-38 (Other Identifier)

Details and patient eligibility

About

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Enrollment

901 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1st Line Consultation in Pediatric Emergencies
  • All reasons for consultation during working hours
  • Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age

Exclusion criteria

  • Refusal of participation by parents/child of decision age
  • No membership of a social security scheme (beneficiary or entitled)
  • No understanding of French

Trial design

901 participants in 1 patient group

Child suspected of infection with COVID-19.
Description:
Child included with positive included
Treatment:
Diagnostic Test: nasopharyngeal swab

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems